Moore joined ECBC in August 2016 as director of Research and Technology Directorate. He served as the center’s acting director beginning in May 2017. Maj. Gen. Cedric Wins, commanding general of the U.S. Army Research, Development and Engineering Command, named Moore permanently to the director’s post in October 2017.

“We only select the finest for leadership positions here, and Dr. Eric Moore certainly meets all those criteria,” Wins said during the ceremony held at the Edgewood Conference Center at Aberdeen Proving Ground, Maryland. “He’s considered by his peers and superiors to be a subject matter expert in these fields. He has a sense of duty and passion for science.”

During the ceremony, Moore discussed his vision for the future of ECBC and alignment with the Army’s three main priorities: readiness, modernization and reform. “We need to envision what the future will look like and partner effectively with our (chemical and biological defense) stakeholders, academia, and industry to develop technologies that give our warfighter the competitive advantage,” Moore said.

“We have to ensure that we’re growing the talent and infrastructure to support tomorrow’s fight,” he continued. “We have to make sure that we’re putting the right business processes in place to deliver quality products and services to tomorrow’s warfighter. And we have to collaborate with one another to deliver tomorrow’s technology using common platforms.”

Throughout his education and career, Moore has gained extensive experience in chemical, biological, radiological, and nuclear (CBRN) defense, as well as medical countermeasures.

After graduating from Fisk University in Nashville, Tennessee, where he was an ROTC cadet and, Moore accepted a commission as a second lieutenant in the Army Medical Service Corps where he supported the Chemical and Biological Defense Program in various roles, including serving at the U.S. Army Medical Research Institute of Chemical Defense.

Later, Moore earned his doctorate in neurophysiology from Meharry Medical College in Nashville. His experience in the U.S. Army also includes positions with the Armed Forces Medical Intelligence Center as the Defense Intelligence Agency’s senior scientific and technical intelligence officer for worldwide CBRN medical countermeasures, as well as the U.S. Army Forensic Toxicology Drug Testing Laboratory, Fort Meade, MD where he served as Commander and Laboratory Director.

Moore’s experience and prestige in the CBRN community made him an exceptional selection for the position of ECBC director, said Wins. “Eric understands clearly ECBC’s mission, how it sees itself, and how he can work to push the center forward in the future,” Wins said. “I have no doubt that Eric Moore is the right guy at the right time, and I’m certain he’s the right pick to lead ECBC forward.”

ECBC is the nation’s primary research and development resource for non-medical chemical and biological defense. ECBC’s experts work safely every day with some of the most dangerous substances on earth to ensure that U.S. and allied warfighters are protected from those threats on the battlefield. ECBC’s 1,400 scientists, engineers, technicians and support personnel provide innovative and cost-effective chemical and biological defense technology solutions. ECBC maintains its main campus at Aberdeen Proving Ground, Maryland, with 1.22 million square feet of laboratory and chamber space spanning 200 buildings worth $2 billion. ECBC also maintains satellite facilities located at Pine Bluff Arsenal, Arkansas; Rock Island Arsenal, Illinois; and Dugway Proving Ground, Utah.